[A comparative evaluation of the antianginal action of commercially and noncommercially produced validol in neurocirculatory dystonia and stenocardia].
As many as 20 patients with neurocirculatory dystonia (NCD) and 10 IHD patients presenting with stable exertional angina were evaluated for an effectiveness of antianginal action of validol tablets commercially- and noncommercially produced, the above tablets being of the changed composition in the latter case. Validol of both changed and unchanged composition had a similar transient antianginal effect which was higher in NCD than it was in angina pectoris. Economical as well as clinical effects of validol of the changed make up warrant it to be commercially produced.
Bondarenko
I P
IP
Liashenko
M M
MM
Chirkov
S N
SN
Ermakovich
I I
II
D000293:Adolescent; D000328:Adult; D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy*; D004341:Drug Evaluation; D004562:Electrocardiography / Q000187:drug effects; D005080:Exercise Test / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000188:drug therapy; D009449:Neurocirculatory Asthenia / Q000175:diagnosis / Q000188:drug therapy*; D013607:Tablets; D014631:Valerates / Q000008:administration & dosage*; D014665:Vasodilator Agents / Q000008:administration & dosage*
D013607:Tablets; D014631:Valerates; D014665:Vasodilator Agents; C012093:Validol